González-Serna D, Villanueva-Martin G, Acosta-Herrera M, Márquez A, Martín J (2020) Approaching shared pathophysiology in immune-mediated diseases through functional genomics. Genes (Basel) 11:1482. https://doi.org/10.3390/genes11121482
Article CAS PubMed Google Scholar
McInnes IB, Gravallese EM (2021) Immune-mediated inflammatory disease therapeutics: past, present and future. Nat Rev Immunol 21:680–686. https://doi.org/10.1038/s41577-021-00603-1
Article CAS PubMed PubMed Central Google Scholar
Ramos PS, Shedlock AM, Langefeld CD (2015) Genetics of autoimmune diseases: insights from population genetics. J Hum Genet 60:657–664. https://doi.org/10.1038/jhg.2015.94
Article CAS PubMed PubMed Central Google Scholar
Gutierrez-Arcelus M, Rich SS, Raychaudhuri S (2016) Autoimmune diseases – connecting risk alleles with molecular traits of the immune system. Nat Rev Genet 17:160–174. https://doi.org/10.1038/nrg.2015.33
Article PubMed PubMed Central Google Scholar
Sun L, Su Y, Jiao A, Wang X, Zhang B (2023) T cells in health and disease. Signal Transduct Target Ther 8:235. https://doi.org/10.1038/s41392-023-01471-y
Article CAS PubMed PubMed Central Google Scholar
National Institutes of Health – National Institute of Allergy and Infectious Diseases. Autoimmune Diseases. Available at: https://www.niaid.nih.gov/diseases-conditions/autoimmune-diseases#:~:text=More%20than%2080%20diseases%20occur,erythematosus%2C%20and%20inflammatory%20bowel%20disease. Accessed on 27 April 2024
El-Gabalawy H, Guenther LC, Bernstein CN (2010) Epidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbidities. J Rheumatol Suppl 85:2–10. https://doi.org/10.3899/jrheum.091461
Conrad N, Misra S, Verbakel JY et al (2023) Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. Lancet 401(10391):1878–1890. https://doi.org/10.1016/S0140-6736(23)00457-9
GBD 2019 IMID Collaborators (2023) Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019. EClinicalMedicine 64:102193. https://doi.org/10.1016/j.eclinm.2023.102193
Fitzgerald K, Hyman M, Swift K (2012) Psoriatic arthritis. Glob Adv. Health Med 1:54–61. https://doi.org/10.7453/gahmj.2012.1.4.009
do Carmo MA, Gleber-Netto FO, Romano ML, Caldeira PC, de Aguiar MC (2014) Clinical and demographic overlaps among immunologically mediated oral diseases: a challenge for clinicians. Gen Dent 62:67–72
Bascones-Martínez A, García-García V, Meurman JH, Requena-Caballero L (2015) Immune-mediated diseases: what can be found in the oral cavity? Int J Dermatol 54:258–270. https://doi.org/10.1111/ijd.12681
Alramadhan SA, Islam MN (2023) Vesiculobullous lesions of the oral cavity. Oral Maxillofac Surg Clin North Am 35:203–217. https://doi.org/10.1016/j.coms.2022.10.006
Suliman NM, Johannessen AC, Ali RW, Salman H, Astrøm AN (2012) Influence of oral mucosal lesions and oral symptoms on oral health related quality of life in dermatological patients: a cross sectional study in Sudan. BMC Oral Health 12:19. https://doi.org/10.1186/1472-6831-12-19
Article PubMed PubMed Central Google Scholar
Bilgic A, Aydin F, Sumer P et al (2020) Oral health related quality of life and disease severity ın autoimmune bullous diseases. Niger J Clin Pract 23:159–164. https://doi.org/10.4103/njcp.njcp_216_19
Article CAS PubMed Google Scholar
Kalinska-Bienias A, Jakubowska B, Kowalewski C, Murrell DF, Wozniak K (2017) Measuring of quality of life in autoimmune blistering disorders in Poland. Validation of disease – specific autoimmune bullous disease quality of life (ABQOL) and the treatment autoimmune bullous disease quality of life (TABQOL) questionnaires. Adv Med Sci 62:92–96. https://doi.org/10.1016/j.advms.2016.07.002
Rashid H, Lamberts A, Diercks GFH et al (2019) Oral lesions in autoimmune bullous diseases: an overview of clinical characteristics and diagnostic algorithm. Am J Clin Dermatol 20:847–861. https://doi.org/10.1007/s40257-019-00461-7
Article PubMed PubMed Central Google Scholar
Carvalho CH, Santos BR, Vieira CC, Lima Ed, Santos PP, Freitas RA (2011) An epidemiological study of immune-mediated skin diseases affecting the oral cavity. An Bras Dermatol 86(5):905–909. https://doi.org/10.1590/s0365-05962011000500007
Arisawa EA, Almeida JD, Carvalho YR, Cabral LA (2008) Clinicopathological analysis of oral mucous autoimmune disease: a 27-year study. Med Oral Patol Oral Cir Bucal 13:E94–E97
Alrashdan MS, Arzmi MH, Ahmad Kamil WN, Al Kawas S, Leao JC (2023) Immune-mediated oral mucosal pathology: a comprehensive review and update for clinicians. Part I. Ital J Dermatol Venerol 158:408–418. https://doi.org/10.23736/S2784-8671.23.07676-4
Alrashdan MS, Andreadis D, Zisis V, Hassona Y (2024) Immune-mediated oral mucosal pathology: a comprehensive review and update for clinicians – part II. Ital J Dermatol Venerol 159:11–22. https://doi.org/10.23736/S2784-8671.23.07690-9
Knottnerus A, Tugwell P (2008) STROBE–a checklist to strengthen the reporting of observational studies in Epidemiology. J Clin Epidemiol 61:323. https://doi.org/10.1016/j.jclinepi.2007.11.006
Kuten-Shorrer M, Menon RS, Lerman MA (2020) Mucocutaneous diseases. Dent Clin North Am 64:139–162. https://doi.org/10.1016/j.cden.2019.08.009
Kulkarni R, Stoopler ET, Sollecito TP (2024) Oral mucous membrane pemphigoid: updates in diagnosis and management. Br Dent J 236:293–296. https://doi.org/10.1038/s41415-024-7064-x
Leuci S, Ruoppo E, Adamo D, Calabria E, Mignogna MD (2000) Oral autoimmune vesicobullous diseases: classification, clinical presentations, molecular mechanisms, diagnostic algorithms, and management. Periodontol 2019(80):77–88. https://doi.org/10.1111/prd.12263
Lourenço SV, de Carvalho FR, Boggio P et al (2007) Lupus erythematosus: clinical and histopathological study of oral manifestations and immunohistochemical profile of the inflammatory infiltrate. J Cutan Pathol 34:558–564. https://doi.org/10.1111/j.1600-0560.2006.00652.x
Aringer M, Costenbader K, Daikh D et al (2019) 2019 European league against rheumatism/American college of rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol 71:1400–1412. https://doi.org/10.1002/art.40930
Article PubMed PubMed Central Google Scholar
Cheng YS, Gould A, Kurago Z, Fantasia J, Muller S (2016) Diagnosis of oral lichen planus: a position paper of the American academy of oral and maxillofacial pathology. Oral Surg Oral Med Oral Pathol Oral Radiol 122:332–354. https://doi.org/10.1016/j.oooo.2016.05.004
Neville BW, Damm DD, Allen CM, Chi AC (2016) Oral & maxillofacial pathology, 4th edn. Elsevier, Missouri
Gonçalves LM, Bezerra Júnior JR, Cruz MC (2010) Clinical evaluation of oral lesions associated with dermatologic diseases. An Bras Dermatol 85:150–156. https://doi.org/10.1590/s0365-05962010000200004
Oliveira Alves MG, Almeida JD, Balducci I, Guimarães Cabral LA (2010) Oral lichen planus: a retrospective study of 110 Brazilian patients. BMC Res Notes 3:157. https://doi.org/10.1186/1756-0500-3-157
Article PubMed PubMed Central Google Scholar
Barbosa NG, Silveira ÉJ, Lima EN, Oliveira PT, Soares MS, de Medeiros AM (2015) Factors associated with clinical characteristics and symptoms in a case series of oral lichen planus. Int J Dermatol 54:e1-6. https://doi.org/10.1111/ijd.
留言 (0)